4tw2 - Revision history

OCA at 15:18, 8 November 2023

OCA — Wed, 08 Nov 2023 15:18:20 GMT

←Older revision		Revision as of 15:18, 8 November 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>		<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.889Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [https://pdbe.org/4tw2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [https://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [https://pdbe.org/4tw2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [https://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>
	</table>		</table>

OCA at 10:58, 15 March 2023

OCA — Wed, 15 Mar 2023 10:58:31 GMT

←Older revision		Revision as of 10:58, 15 March 2023
Line 3:		Line 3:
	<StructureSection load='4tw2' size='340' side='right'caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>		<StructureSection load='4tw2' size='340' side='right'caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4tvz\|4tvz]], [[4tw0\|4tw0]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [https://pdbe.org/4tw2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [https://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">SCARB2, CD36L2, LIMP2, LIMPII ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [~~http~~://pdbe.org/4tw2 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN]] Unverricht-Lundborg disease;Gaucher disease type 1;Action myoclonus - renal failure syndrome. The disease is caused by mutations affecting the gene represented in this entry. Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease.	+	[https://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN] Unverricht-Lundborg disease;Gaucher disease type 1;Action myoclonus - renal failure syndrome. The disease is caused by mutations affecting the gene represented in this entry. Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease.
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN]] Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.<ref>PMID:18022370</ref>	+	[https://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN] Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.<ref>PMID:18022370</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 26:		Line 24:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Dang~~, M H~~]]	+	[[Category: Dang MH]]
-	[[Category: Rao~~, Z H~~]]	+	[[Category: Rao ZH]]
-	[[Category: Wang~~, X X]]~~	+	[[Category: Wang XX]]
-	~~[[Category: Lipid binding tunnel]]~~	+
-	~~[[Category: Protein binding~~]]	+

OCA at 14:15, 10 May 2019

OCA — Fri, 10 May 2019 14:15:52 GMT

←Older revision		Revision as of 14:15, 10 May 2019
Line 1:		Line 1:

	==Crystal Structure of SCARB2 in Neural Condition (pH7.5)==		==Crystal Structure of SCARB2 in Neural Condition (pH7.5)==
-	<StructureSection load='4tw2' size='340' side='right' caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>	+	<StructureSection load='4tw2' size='340' side='right'caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4tvz\|4tvz]], [[4tw0\|4tw0]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4tvz\|4tvz]], [[4tw0\|4tw0]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">SCARB2, CD36L2, LIMP2, LIMPII ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [http://pdbe.org/4tw2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [http://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [http://pdbe.org/4tw2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [http://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>
	</table>		</table>
Line 25:		Line 26:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Dang, M H]]		[[Category: Dang, M H]]
	[[Category: Rao, Z H]]		[[Category: Rao, Z H]]

OCA at 13:26, 19 April 2017

OCA — Wed, 19 Apr 2017 13:26:54 GMT

←Older revision		Revision as of 13:26, 19 April 2017
Line 1:		Line 1:
		+
	==Crystal Structure of SCARB2 in Neural Condition (pH7.5)==		==Crystal Structure of SCARB2 in Neural Condition (pH7.5)==
	<StructureSection load='4tw2' size='340' side='right' caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>		<StructureSection load='4tw2' size='340' side='right' caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>
Line 5:		Line 6:
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4tvz\|4tvz]], [[4tw0\|4tw0]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4tvz\|4tvz]], [[4tw0\|4tw0]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [http://www.ebi.ac.uk/pdbsum/4tw2 PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [http://pdbe.org/4tw2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [http://www.ebi.ac.uk/pdbsum/4tw2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4tw2 ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 19:		Line 20:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4tw2" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 14:43, 8 July 2015

OCA — Wed, 08 Jul 2015 14:43:38 GMT

←Older revision		Revision as of 14:43, 8 July 2015
Line 1:		Line 1:
-	'''~~Unreleased~~ structure'''	+	==Crystal Structure of SCARB2 in Neural Condition (pH7.5)==
		+	<StructureSection load='4tw2' size='340' side='right' caption='[[4tw2]], [[Resolution\|resolution]] 2.89Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4tw2]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TW2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TW2 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4tvz\|4tvz]], [[4tw0\|4tw0]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tw2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tw2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4tw2 RCSB], [http://www.ebi.ac.uk/pdbsum/4tw2 PDBsum]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN]] Unverricht-Lundborg disease;Gaucher disease type 1;Action myoclonus - renal failure syndrome. The disease is caused by mutations affecting the gene represented in this entry. Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN]] Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.<ref>PMID:18022370</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Unlike the well-established picture for the entry of enveloped viruses, the mechanism of cellular entry of non-enveloped eukaryotic viruses remains largely mysterious. Picornaviruses are representative models for such viruses, and initiate this entry process by their functional receptors. Here we present the structural and functional studies of SCARB2, a functional receptor of the important human enterovirus 71 (EV71). SCARB2 is responsible for attachment as well as uncoating of EV71. Differences in the structures of SCARB2 under neutral and acidic conditions reveal that SCARB2 undergoes a pivotal pH-dependent conformational change which opens a lipid-transfer tunnel to mediate the expulsion of a hydrophobic pocket factor from the virion, a pre-requisite for uncoating. We have also identified the key residues essential for attachment to SCARB2, identifying the canyon region of EV71 as mediating the receptor interaction. Together these results provide a clear understanding of cellular attachment and initiation of uncoating for enteroviruses.

-	~~The entry 4tw2 is ON HOLD until Paper Publication~~	+	Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71.,Dang M, Wang X, Wang Q, Wang Y, Lin J, Sun Y, Li X, Zhang L, Lou Z, Wang J, Rao Z Protein Cell. 2014 Sep;5(9):692-703. doi: 10.1007/s13238-014-0087-3. Epub 2014, Jul 2. PMID:24986489<ref>PMID:24986489</ref>

-	~~Authors: Dang~~, M.H.~~, Wang, X.X., Rao, Z.H~~.	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)~~	+	== References ==
-	[[Category: ~~Unreleased Structures~~]]	+	<references/>
-	[[Category: Rao, Z.H]]	+	__TOC__
-	[[Category: Wang, X.X]]	+	</StructureSection>
-	[[Category: ~~Dang, M.H~~]]	+	[[Category: Dang, M H]]
		+	[[Category: Rao, Z H]]
		+	[[Category: Wang, X X]]
		+	[[Category: Lipid binding tunnel]]
		+	[[Category: Protein binding]]

OCA at 17:54, 24 December 2014

OCA — Wed, 24 Dec 2014 17:54:37 GMT

←Older revision		Revision as of 17:54, 24 December 2014
Line 6:		Line 6:

	Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)		Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)
		+	[[Category: Unreleased Structures]]
		+	[[Category: Rao, Z.H]]
		+	[[Category: Wang, X.X]]
		+	[[Category: Dang, M.H]]

OCA at 08:41, 24 September 2014

OCA — Wed, 24 Sep 2014 08:41:13 GMT

←Older revision		Revision as of 08:41, 24 September 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4tw2 is ON HOLD	+	The entry 4tw2 is ON HOLD until Paper Publication

	Authors: Dang, M.H., Wang, X.X., Rao, Z.H.		Authors: Dang, M.H., Wang, X.X., Rao, Z.H.

	Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)		Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)

OCA: Protected "4tw2" [edit=sysop:move=sysop]

OCA — Wed, 09 Jul 2014 06:59:40 GMT

Protected "4tw2" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:59, 9 July 2014

OCA: New page: '''Unreleased structure''' The entry 4tw2 is ON HOLD Authors: Dang, M.H., Wang, X.X., Rao, Z.H. Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)

OCA — Wed, 09 Jul 2014 06:59:39 GMT

New page: '''Unreleased structure''' The entry 4tw2 is ON HOLD Authors: Dang, M.H., Wang, X.X., Rao, Z.H. Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)

New page

'''Unreleased structure'''

The entry 4tw2 is ON HOLD

Authors: Dang, M.H., Wang, X.X., Rao, Z.H.

Description: Crystal Structure of SCARB2 in Neural Condition (pH7.5)